← Evidence map

ArticleDrug discovery today2026

Daraxonrasib in pancreatic cancer: When progress disrupts practice.

Asfar S Azmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42567220